RPS6KB1 and neoplasm: In line with the inhibition of the mTORC1 pathway by C118P administration in vitro as shown in Figure 4, a clear reduction in the protein expression of RAB1A, p-mTOR, and p-p70S6K was observed in the tumor tissues of C118P-treated mice compared to the negative controls, suggesting the inhibitory effect of C118P on the RAB1A-mTOR axis in vivo (Figure 8G,H).